3 Reasons Pfizer Is A Screaming Buy Right Now

Posted On October 17, 2016 3:28 pm

Many people don’t realize it but the easiest way to get rich in the stock market isn’t with the next super-mega-growth stock, but often with boring, well known, dividend growth blue chips. Find out why Pfizer is looking especially attractive now, both from a valuation point of view, and in terms of potentially delivering market thumping total returns over the next decade.

Continue Reading Here

About author

Dividend Sensei

I'm an Army veteran and former energy dividend writer for The Motley Fool. I'm a proud co-founder of Wide Moat Research, Dividend Kings, and the Intelligent Dividend Investor. My work can be found on Seeking Alpha, Dividend Kings, iREIT, and the Intelligent Dividend Investor. My goal is to help all people learn how to harness the awesome power of dividend growth investing to achieve their financial dreams and enrich their lives. With 24 years of investing experience, I've learned what works and more importantly, what doesn't, when it comes to building long-term wealth and income streams and achieving long-term financial goals.

Related Articles

Leave a reply

Your email address will not be published. Required fields are marked *